Adjuvant crizotinib treatment selected by patient-derived organoids in a patient with stage IIIA adenocarcinoma with novel LRRTM4-ALK fusion: a case report

Bowen Li, Ziqi Jia, Zhicheng Huang, Jianchao Xue, Yadong Wang, Chao Guo, Xiaoyan Si, Zexin Chen, Ji Li, Rongrong Chen, Zhixin Bie, Andrea De Giglio, Petros Christopoulos, Naixin Liang, Shanqing Li